AZ

Alejandro Zaffaroni

North America, California, United States, Mountain View

Description

Alejandro Zaffaroni (1923-2014) founded many companies, including Alexza Pharmaceuticals. A native of Montevideo, Uruguay, Dr. Zaffaroni rec...

Investor Profile

Alejandro Zaffaroni has made 4 investments, with 0 in the past 12 months and 25% as lead.

Stage Focus

  • Series A (25%)
  • Series D (25%)
  • Series C (25%)
  • Series B (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Developer Platform
  • Genetics
  • Innovation Management
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Alejandro Zaffaroni frequently co-invest with?

Abingworth
Europe, England, United Kingdom, London
Co-Investments: 1
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 1
Alloy Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
Skyline Ventures
North America, California, United States, Palo Alto
Co-Investments: 1
CMEA Ventures
North America, California, United States, San Francisco
Co-Investments: 3
Frazier Healthcare Partners
North America, Washington, United States, Seattle
Co-Investments: 2
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
Delphi Ventures
North America, California, United States, San Mateo
Co-Investments: 1
Venrock
North America, California, United States, Palo Alto
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Alejandro Zaffaroni?

Alexza Pharmaceuticals

Mountain View, California, United States

Alexza Pharmaceuticals is a pharmaceutical company developing novel products for the treatment of acute and intermittent conditions.

BiotechnologyHealth CarePharmaceutical
Series DJan 6, 2005
Amount Raised: $52,000,000
Perlegen Sciences

Mountain View, California, United States

Perlegen Sciences develops genetic variations providing physicians with information to improve the clinical process and treatment outcomes.

BiotechnologyGeneticsHealth CarePharmaceutical
Series CJan 28, 2003
Amount Raised: $30,000,000
Senomyx

San Diego, California, United States

Sensing the Future Through Innovation

BiotechnologyInnovation Management
Series BSep 21, 2000
Amount Raised: $10,000,000
Xenoport

Santa Clara, California, United States

XenoPort is a biopharmaceutical company that develops a portfolio of product candidates to treat neurological disorders.

BiotechnologyDeveloper PlatformPharmaceutical
Series AFeb 1, 2000
Amount Raised: $15,870,000